Synthesis and biological activity of 3'-hydroxy-5'-aminobenzoxazinorifamycin derivatives. - Wikidata - wikimedia - TriplyDB

Synthesis and biological activity of 3'-hydroxy-5'-aminobenzoxazinorifamycin derivatives.

Synthesis and biological activity of 3'-hydroxy-5'-aminobenzoxazinorifamycin derivatives.

http://www.wikidata.org/entity/Q42558952

about

Mechanism of action of antimycobacterial activity of the new benzoxazinorifamycin KRM-1648 In vitro activity of the benzoxazinorifamycin KRM-1648 against drug-susceptible and multidrug-resistant tubercle bacilli Activity of KRM-1648, a new benzoxazinorifamycin, against Mycobacterium tuberculosis in a murine model Activities of the benzoxazinorifamycin KRM 1648 and ethambutol against Mycobacterium avium complex in vitro and in macrophages In vitro and in vivo antibacterial activities of KRM-1648 and KRM-1657, new rifamycin derivatives In vitro and in vivo activities of the benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis Activity of KRM-1648 in combination with isoniazid against Mycobacterium tuberculosis in a murine model Anticytomegaloviral activity of methotrexate associated with preferential accumulation of drug by cytomegalovirus-infected cells How effective is KRM-1648 in treatment of disseminated Mycobacterium avium complex infections in beige mice?Comparative antimycobacterial activities of rifampin, rifapentine, and KRM-1648 against a collection of rifampin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations Activities of rifamycin derivatives against wild-type and rpoB mutants of Chlamydia trachomatis Natural products to drugs: natural product-derived compounds in clinical trials.Development potential of rifalazil.Effects of benzoxazinorifamycin KRM-1648 on cytokine production at sites of Mycobacterium avium complex infection induced in mice Natural products to drugs: natural product derived compounds in clinical trials.Drugs versus bugs: in pursuit of the persistent predator Mycobacterium tuberculosis.In vitro anti-Helicobacter pylori activities of new rifamycin derivatives, KRM-1648 and KRM-1657.Pharmacokinetics of KRM-1648, a new benzoxazinorifamycin, in rats and dogs.Antimicrobial agent resistance in mycobacteria: molecular genetic insights.Antimicrobial activities of cinnamyl rifamycin derivatives, T-9 and T-11, against Mycobacterium tuberculosis and Mycobacterium avium complex (MAC) with special reference to the activities against intracellular MAC.Identification of enzymes responsible for rifalazil metabolism in human liver microsomes.

P2860

Q28367444-E0A19229-F388-4FDF-82C8-61EACF0F715D Q28368095-05D27ECD-AC02-41A2-973E-5EA3BD956BDD Q28368360-A4538E7F-D828-4E61-A6D1-6D60D11CE314 Q28369151-115F74F5-0A8F-42B3-AACA-D85005549A66 Q28369383-4ABA0E5A-9DB0-4EA4-B18C-74AC3A784564 Q28378826-495D62B2-3E04-4C86-840F-36A4E6FD8FD3 Q28379169-87A106D5-3E24-491E-992A-D95725B7A7B4 Q28379178-20ADDFF8-D470-4F57-9B23-F0C2DF295B93 Q28379180-870F5E1B-0CC6-431A-BBB5-23E92ACA6322 Q28379306-27C9C3F5-E8C3-4579-899B-FF953B88821C Q33935250-4E65DDEF-7C28-4A35-BBFC-D61D8A43C98D Q34780898-512E1A90-5478-4433-A2A7-8C67FDABC8D6 Q35056073-F4AB9A6E-89B5-4B65-8924-B5EDADD80AE9 Q35132348-0F981B36-3041-4D6D-934D-41251B180FAF Q36087066-E2965261-A367-4094-905B-9D53EE7ECDA8 Q37031891-BDA16AB2-7B36-4226-B786-5742D4F8C4E1 Q39470015-F2F2B12F-C3B5-485E-9E03-17816D03C7D4 Q39783255-DBDA0CF1-00BC-4A7F-9C19-B32B98802679 Q39820619-E9024FB7-6E7E-4002-B5AB-7060CDBD9193 Q40241129-4B100766-0F31-434E-92E7-F484E66FE38A Q43505733-AB8338FA-54E3-4BB8-A924-957B653B2774

P2860

Synthesis and biological activity of 3'-hydroxy-5'-aminobenzoxazinorifamycin derivatives.

http://www.wikidata.org/entity/Q42558952

description

1993 nî lūn-bûn

@nan

1993年の論文

@ja

1993年論文

@yue

1993年論文

@zh-hant

1993年論文

@zh-hk

1993年論文

@zh-mo

1993年論文

@zh-tw

1993年论文

@wuu

1993年论文

@zh

1993年论文

@zh-cn

name

Synthesis and biological activity of 3'-hydroxy-5'-aminobenzoxazinorifamycin derivatives.

@en

Synthesis and biological activity of 3'-hydroxy-5'-aminobenzoxazinorifamycin derivatives.

@nl

type

label

Synthesis and biological activity of 3'-hydroxy-5'-aminobenzoxazinorifamycin derivatives.

@en

Synthesis and biological activity of 3'-hydroxy-5'-aminobenzoxazinorifamycin derivatives.

@nl

prefLabel

Synthesis and biological activity of 3'-hydroxy-5'-aminobenzoxazinorifamycin derivatives.

@en

Synthesis and biological activity of 3'-hydroxy-5'-aminobenzoxazinorifamycin derivatives.

@nl

P1433

Q42558952-C31B0CEC-8973-4B07-AB86-626A5747E1B9

P1476

Q42558952-CF30B0DF-5EA8-4BEA-B0A9-D000DF3BAF19

P2093

Q42558952-35BCEFD5-F2B9-4FA8-B0C1-EC8C021DBCD6

Q42558952-5283D434-A904-4A86-88BC-B4870FE8A097

Q42558952-95D07D73-5899-462E-B5E3-BB6DBBB61ABA

Q42558952-A9505424-5258-4F43-8CF0-DA435F18E022

Q42558952-AE329B76-31AE-4C8A-81C2-87D5FA9F2DB2

Q42558952-BAABC327-1BE1-4475-92B4-17B7CB1ED7D8

Q42558952-BBD88863-12F2-4C7E-B34E-04B13BD109C8

Q42558952-BC34852B-B6D6-47D1-873C-23664A32CC58

Q42558952-DBE17084-1A27-4BC0-8709-C00EDB8BA6EF

Q42558952-EDE692C0-7800-4E6A-A17B-BC0FF0EF0EA1

P304

Q42558952-8A7976C5-E18B-4299-B6D6-5C58DF2DF2DF

P31

Q42558952-BB287CF6-8250-452B-BCB7-E4E714CE9097

P356

Q42558952-11FF7BEF-C0D9-470F-9DC9-1C37BEF57307

P407

Q42558952-74E5470D-0FC3-4703-874F-3B6A6DFA23E0

P433

Q42558952-67ABF530-752D-4D31-A0D3-927B33DF7D5C

P478

Q42558952-E88948E6-2948-4FA7-84BB-4C6FC982AD63

P577

Q42558952-1D803847-44E8-4F05-9929-F854B5F8D2B8

P698

Q42558952-FB14D58B-7297-46FE-88F9-EF60F82379B9

P356

P1433

Chemical & Pharmaceutical Bulletin

P1476

Synthesis and biological activity of 3'-hydroxy-5'-aminobenzoxazinorifamycin derivatives.

@en

P2093

Hashizume T

http://www.w3.org/2001/XMLSchema#string

Hidaka T

http://www.w3.org/2001/XMLSchema#string

Hosoe K

http://www.w3.org/2001/XMLSchema#string

Kawaharada H

http://www.w3.org/2001/XMLSchema#string

Konishi E

http://www.w3.org/2001/XMLSchema#string

Kuze F

http://www.w3.org/2001/XMLSchema#string

Watanabe K

http://www.w3.org/2001/XMLSchema#string

Yamamoto T

http://www.w3.org/2001/XMLSchema#string

Yamane T

http://www.w3.org/2001/XMLSchema#string

Yamashita K

http://www.w3.org/2001/XMLSchema#string

P304

148-155

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1248/CPB.41.148

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P577

1993-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8448815

http://www.w3.org/2001/XMLSchema#string